Ausgabe 6/2016
Inhalt (13 Artikel)
Open Access
Cardiac contractility modulation: a novel approach for the treatment of heart failure
Freddy Abi-Samra, David Gutterman
Cognitive decline in heart failure
Kannayiram Alagiakrishnan, Darren Mah, Ali Ahmed, Justin Ezekowitz
The treatment gap in patients with chronic systolic heart failure: a systematic review of evidence-based prescribing in practice
Ken Lee Chin, Marina Skiba, Andrew Tonkin, Christopher M. Reid, Danny Liew, Henry Krum, Ingrid Hopper
Should MRAs be at the front row in heart failure? A plea for the early use of mineralocorticoid receptor antagonists in medical therapy for heart failure based on clinical experience
Ward A. Heggermont, Marc Goethals, Riet Dierckx, Sofie Verstreken, Jozef Bartunek, Marc Vanderheyden
Stem cells and diabetic cardiomyopathy: from pathology to therapy
Mingfei Liu, Han Chen, Jun Jiang, Zhaocai Zhang, Chen Wang, Na Zhang, Liang Dong, Xinyang Hu, Wei Zhu, Hong Yu, Jian’an Wang
New strategies for improving stem cell therapy in ischemic heart disease
Peisen Huang, Xiaqiu Tian, Qing Li, Yuejin Yang
The evolving role of adiponectin as an additive biomarker in HFrEF
Tahnee Sente, Andreas Gevaert, An Van Berendoncks, Christiaan J. Vrints, Vicky Y. Hoymans
Cardiac injury biomarkers in paediatric age: Are we there yet?
Ana L. Neves, Tiago Henriques-Coelho, Adelino Leite-Moreira, José C. Areias
Myocardial transcription factors in diastolic dysfunction: clues for model systems and disease
Alexander T. Mikhailov, Mario Torrado
Open Access
Personalised computational cardiology: Patient-specific modelling in cardiac mechanics and biomaterial injection therapies for myocardial infarction
Kevin L. Sack, Neil H. Davies, Julius M. Guccione, Thomas Franz